Pasithea Therapeutics Corp. (KTTAW) Financial Statements (2026 and earlier)
Company Profile
| Business Address |
1111 LINCOLN ROAD, SUITE 500 MIAMI BEACH, FL 33139 |
| State of Incorp. | DE |
| Fiscal Year End | December 31 |
| Industry (SIC) | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete Financial Analysis Financial Benchmarking |
Balance Sheet (Statement of Financial Position) ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |||
|---|---|---|---|---|---|---|---|
| ASSETS | |||||||
| Current Assets | |||||||
| Cash, cash equivalents, and short-term investments | 6,923 | 16,331 | 33,147 | 52,967 | |||
| Cash and cash equivalent | 6,923 | 16,331 | 33,147 | 52,967 | |||
| Prepaid expense | 303 | 216 | 628 | 334 | |||
| Other current assets | 143 | 105 | 302 | ||||
| Other undisclosed current assets | 41 | ||||||
| Total current assets: | 7,368 | 16,692 | 34,077 | 53,300 | |||
| Noncurrent Assets | |||||||
| Operating lease, right-of-use asset | 79 | 874 | |||||
| Property, plant, and equipment, after accumulated depreciation, depletion, and amortization | 122 | 141 | 379 | 20 | |||
| Intangible asset, including goodwill, after accumulated amortization | 8,574 | 9,204 | 9,850 | ||||
| Goodwill | 1,263 | 1,263 | 1,263 | ||||
| Intangible asset, excluding goodwill, after accumulated amortization | 7,311 | 7,941 | 8,587 | ||||
| Other undisclosed noncurrent assets | |||||||
| Total noncurrent assets: | 8,696 | 9,425 | 11,103 | 20 | |||
| TOTAL ASSETS: | 16,065 | 26,117 | 45,180 | 53,321 | |||
| LIABILITIES AND EQUITY | |||||||
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts payable and accrued liabilities, including: | 1,120 | 2,552 | 1,614 | 447 | |||
| Other undisclosed accounts payable and accrued liabilities | 1,120 | 2,552 | 1,614 | 447 | |||
| Other undisclosed current liabilities | 82 | 263 | |||||
| Total current liabilities: | 1,120 | 2,634 | 1,878 | 447 | |||
| Noncurrent Liabilities | |||||||
| Liabilities, other than long-term debt | 804 | ||||||
| Operating lease, liability | 664 | ||||||
| Derivative instruments and hedges, liabilities | 141 | ||||||
| Other undisclosed noncurrent liabilities | 162 | 84 | 1,453 | ||||
| Total noncurrent liabilities: | 162 | 84 | 804 | 1,453 | |||
| Total liabilities: | 1,282 | 2,718 | 2,682 | 1,900 | |||
| Equity | |||||||
| Equity, attributable to parent | 14,783 | 23,398 | 42,498 | 51,421 | |||
| Common stock | 0 | 0 | 18 | 18 | |||
| Additional paid in capital | 64,372 | 58,722 | 61,838 | 53,628 | |||
| Accumulated other comprehensive income (loss) | (7) | (5) | (1) | (11) | |||
| Accumulated deficit | (49,583) | (35,319) | (19,357) | (2,215) | |||
| Total equity: | 14,783 | 23,398 | 42,498 | 51,421 | |||
| TOTAL LIABILITIES AND EQUITY: | 16,065 | 26,117 | 45,180 | 53,321 | |||
Income Statement (P&L) ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|---|
| Revenues | 65 | 487 | 15 | |||
| Gain on disposition of assets for financial service operations | 65 | |||||
| Other income | 880 | |||||
| Cost of revenue (Cost of Product and Service Sold) | (17) | |||||
| Gross profit: | 65 | 487 | (2) | |||
| Operating expenses | (14,250) | (15,979) | (15,190) | (4,505) | ||
| Other undisclosed operating loss | (65) | (113) | ||||
| Operating loss: | (14,250) | (15,979) | (14,816) | (4,507) | ||
| Nonoperating income | 345 | 472 | 2,334 | |||
| Investment income, nonoperating | 423 | |||||
| Other nonoperating income | 472 | |||||
| Interest and debt expense | 45 | |||||
| Loss from continuing operations before equity method investments, income taxes: | (13,905) | (15,508) | (14,772) | (2,174) | ||
| Other undisclosed income from continuing operations before income taxes | 835 | |||||
| Loss from continuing operations: | (13,905) | (15,508) | (13,936) | (2,174) | ||
| Loss before gain (loss) on sale of properties: | ✕ | ✕ | ✕ | ✕ | (2,174) | |
| Loss from discontinued operations | (454) | |||||
| Net loss available to common stockholders, diluted: | (13,905) | (15,962) | (13,936) | (2,174) | ||
Comprehensive Income ($ in thousands)
| 12/31/2025 | 12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | ||
|---|---|---|---|---|---|---|
| Net loss: | (13,905) | (15,962) | (13,936) | (2,174) | ||
| Other comprehensive income (loss) | 3 | (300) | ||||
| Comprehensive loss: | (13,902) | (15,962) | (14,236) | (2,174) | ||
| Other undisclosed comprehensive income (loss), net of tax, attributable to parent | (5) | (4) | 310 | (11) | ||
| Comprehensive loss, net of tax, attributable to parent: | (13,907) | (15,966) | (13,927) | (2,184) | ||
Statements Sources
The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.